Trials / Terminated
TerminatedNCT02989168
Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest
A Phase II Open Label Study to Evaluate the Effect of GBT440 on Hypoxemia in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Who Are Using Supplemental Oxygen at Rest (ZEPHYR)
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Global Blood Therapeutics · Industry
- Sex
- All
- Age
- 45 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label study in which eligible IPF subjects who are using supplemental oxygen at rest will receive GBT440 orally daily.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GBT440 | GBT440: Capsules which contain GBT440 drug substance in Swedish orange |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-10-23
- Completion
- 2017-10-23
- First posted
- 2016-12-12
- Last updated
- 2020-08-21
- Results posted
- 2020-08-21
Locations
9 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT02989168. Inclusion in this directory is not an endorsement.